Volume 22, Issue 2, Pages (February 2015)

Slides:



Advertisements
Similar presentations
Rational Design of Combination Enzyme Therapy for Celiac Sprue
Advertisements

MRI-Based Detection of Alkaline Phosphatase Gene Reporter Activity Using a Porphyrin Solubility Switch  Gil G. Westmeyer, Yelena Emer, Jutta Lintelmann,
Volume 22, Issue 7, Pages (July 2015)
Covalent Reactions of Wortmannin under Physiological Conditions
Volume 5, Issue 2, Pages (August 2009)
A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities  Xiaoqiong Wu, Siqi Chen, Limin Lin, Jiayu Liu, Yanlan Wang, Yumei Li, Qing Li,
Volume 15, Issue 2, Pages (February 2007)
Volume 21, Issue 8, Pages (August 2014)
Shoutian Zhu, Kevin T. Mc Henry, William S. Lane, Gabriel Fenteany 
Volume 14, Issue 5, Pages (May 2007)
Volume 28, Issue 3, Pages (September 2015)
Grigory S. Filonov, Vladislav V. Verkhusha  Chemistry & Biology 
Volume 24, Issue 10, Pages (October 2016)
Volume 21, Issue 11, Pages (November 2014)
Mapping Proteome-wide Targets of Glyphosate in Mice
Rational Design of Combination Enzyme Therapy for Celiac Sprue
Volume 21, Issue 11, Pages (November 2014)
Volume 14, Issue 7, Pages (July 2007)
Highly Efficient Self-Replicating RNA Enzymes
MRI-Based Detection of Alkaline Phosphatase Gene Reporter Activity Using a Porphyrin Solubility Switch  Gil G. Westmeyer, Yelena Emer, Jutta Lintelmann,
Volume 19, Issue 7, Pages (July 2012)
Volume 17, Issue 9, Pages (September 2010)
Volume 22, Issue 7, Pages (July 2015)
Volume 22, Issue 3, Pages (March 2015)
Small Molecule Fluoride Toxicity Agonists
Grigory S. Filonov, Vladislav V. Verkhusha  Chemistry & Biology 
Volume 14, Issue 7, Pages (July 2007)
Volume 24, Issue 11, Pages e4 (November 2017)
Small Molecule Fluoride Toxicity Agonists
Volume 19, Issue 4, Pages (April 2012)
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Volume 14, Issue 10, Pages (October 2007)
Volume 18, Issue 11, Pages (November 2011)
Mitochondria-Penetrating Peptides
Volume 16, Issue 2, Pages (February 2009)
Volume 19, Issue 12, Pages (December 2012)
Volume 19, Issue 6, Pages (June 2012)
Volume 21, Issue 3, Pages (March 2014)
Volume 24, Issue 8, Pages e4 (August 2017)
Volume 20, Issue 2, Pages (February 2013)
Stable and Potent Selenomab-Drug Conjugates
Volume 18, Issue 3, Pages (March 2011)
Volume 17, Issue 4, Pages (April 2010)
Volume 18, Issue 11, Pages (November 2011)
Chemical Dissection of an Essential Redox Switch in Yeast
Volume 16, Issue 2, Pages (February 2009)
Jae Won Chang, Daniel K. Nomura, Benjamin F. Cravatt 
Volume 24, Issue 12, Pages e5 (December 2017)
Volume 20, Issue 5, Pages (May 2013)
Volume 22, Issue 7, Pages (July 2015)
Inhibitor Mediated Protein Degradation
An Electrophoretic Mobility Shift Assay Identifies a Mechanistically Unique Inhibitor of Protein Sumoylation  Yeong Sang Kim, Katelyn Nagy, Samantha Keyser,
Volume 22, Issue 8, Pages (August 2015)
Volume 19, Issue 8, Pages (August 2012)
Volume 18, Issue 2, Pages (February 2011)
Molecular Therapy - Oncolytics
Volume 17, Issue 6, Pages (June 2010)
Volume 22, Issue 7, Pages (July 2015)
Volume 20, Issue 2, Pages (February 2013)
Volume 18, Issue 1, Pages (January 2011)
Morgan E. DeSantis, James Shorter  Chemistry & Biology 
Volume 21, Issue 9, Pages (September 2014)
Volume 15, Issue 9, Pages (September 2008)
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Volume 23, Issue 4, Pages (April 2015)
Volume 18, Issue 11, Pages (November 2011)
Volume 16, Issue 9, Pages (September 2009)
Volume 17, Issue 8, Pages (August 2010)
Covalent Reactions of Wortmannin under Physiological Conditions
Volume 21, Issue 9, Pages (September 2014)
Presentation transcript:

Volume 22, Issue 2, Pages 293-298 (February 2015) Generating Site-Specifically Modified Proteins via a Versatile and Stable Nucleophilic Carbon Ligation  Romas Kudirka, Robyn M. Barfield, Jesse McFarland, Aaron E. Albers, Gregory W. de Hart, Penelope M. Drake, Patrick G. Holder, Stefanie Banas, Lesley C. Jones, Albert W. Garofalo, David Rabuka  Chemistry & Biology  Volume 22, Issue 2, Pages 293-298 (February 2015) DOI: 10.1016/j.chembiol.2014.11.019 Copyright © 2015 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2015 22, 293-298DOI: (10. 1016/j. chembiol. 2014 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Overview of the Trapped-Knoevenagel Ligation Using a Thiopyrazolone Nucleophile (A) Generation of C-terminally tagged αΗΕR2-thioPz-ADC. (B) Reaction of a model thiopyrazolone 1 to generate tetrahydrothiopyranopyrazolone 2, through the enone generated via a Knoevenagel condensation. Chemistry & Biology 2015 22, 293-298DOI: (10.1016/j.chembiol.2014.11.019) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Building Block Synthesis and Conjugation Constructs (A) Synthetic route to thioPz building block. (B) Structures of thioPz-maytansine construct (6) and aminooxy-maytansine construct (7). Chemistry & Biology 2015 22, 293-298DOI: (10.1016/j.chembiol.2014.11.019) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 ThioPz Conjugation Is Faster Than Aminooxy Conjugation with fGly-Tagged Antibodies across a Variety of pH Values The fGly-αHER2 antibody (1.9 mg ml−1) was conjugated to thioPz compound 6 (1 mM) or aminooxy compound 7 (1 mM) at 37°C in 100 mM sodium citrate (pH 5–7) or 100 mM potassium acetate (pH 4.6), 25 mM sodium chloride in the presence of 1% dimethyl adipimidate (DMA), and 0.25% Triton X-100. Analytical HIC was used to monitor the disappearance of starting material. Chemistry & Biology 2015 22, 293-298DOI: (10.1016/j.chembiol.2014.11.019) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 4 Conjugations with the Trapped-Knoevenagel Ligation Are Stable in Plasma at 37°C ADCs made by conjugating C-terminally tagged αHER2 with either a thioPz-maytansine (6) or an aminooxy-maytansine payload (7) were spiked into human plasma and incubated at 37°C for up to 1 week. Samples were analyzed by ELISA for anti-maytansine and anti-human Fc reactivity. The ratio of the two signals was used as a measure of conjugation. The oxime conjugate decomposed rapidly, with a t1/2 of <1 day (blue). By contrast, the thioPz conjugate demonstrated minimal loss (13%) of conjugate during the course of the experiment, corresponding to a t1/2 of 35 days (green). Error bars indicate the SD of four technical replicates. Chemistry & Biology 2015 22, 293-298DOI: (10.1016/j.chembiol.2014.11.019) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 5 The αHER2 ADC Made Using the Trapped-Knoevenagel Ligation Is Highly Active In Vitro and In Vivo against the HER2-Overexpressing NCI-N87 Tumor Model (A) In vitro cytotoxicity. NCI-N87 cells were treated with varying concentrations of αHER2-thioPz-ADC (green), isotype ADC (blue), or free maytansine (black). After a 6 day incubation period, cell viability was assessed using CellTiter Glo. IC50 values were determined using GraphPad Prism. Error bars represent the SD of nine biological replicates of three technical replicates. (B) In vivo efficacy. SCID mice bearing NCI-N87 tumors on their flank were dosed (5 mg kg−1 of ADC) with αHER2-thioPz-ADC (green) once a week for 4 weeks. An isotype control ADC (blue), untagged αHER2 antibody (orange), and vehicle alone (gray) were used as negative controls. Error bars indicate the SEM; n = 8 mice per group. Chemistry & Biology 2015 22, 293-298DOI: (10.1016/j.chembiol.2014.11.019) Copyright © 2015 Elsevier Ltd Terms and Conditions